相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Differing associations between Ab accumulation, hypoperfusion, blood-brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease
J. Scott Miners et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2018)
Vascular pathology in multiple sclerosis: reframing pathogenesis around the blood-brain barrier
Jonathan I. Spencer et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Acute formaldehyde exposure induced early Alzheimer-like changes in mouse brain
Xudong Liu et al.
TOXICOLOGY MECHANISMS AND METHODS (2018)
Acute formaldehyde exposure induced early Alzheimer-like changes in mouse brain
Xudong Liu et al.
TOXICOLOGY MECHANISMS AND METHODS (2018)
The Blood Brain Barrier and its Role in Alzheimer's Therapy: An Overview
Satya Lavanya Jakki et al.
CURRENT DRUG TARGETS (2018)
Humanin Exerts Neuroprotection During Cardiac Ischemia-Reperfusion Injury
Sirinart Kumfu et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Targeted inhibition of RAGE reduces amyloid-β influx across the blood-brain barrier and improves cognitive deficits in db/db mice
Hao Wang et al.
NEUROPHARMACOLOGY (2018)
Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link
Jaime Ramos-Cejudo et al.
EBIOMEDICINE (2018)
Neuroprotective effect of formononetin in ameliorating learning and memory impairment in mouse model of Alzheimer's disease
Hong-Xin Fei et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2018)
Annexin A1 restores Aβ1-42-induced blood-brain barrier disruption through the inhibition of RhoA-ROCK signaling pathway
Jong-Chan Park et al.
AGING CELL (2017)
Plasma levels of soluble receptor for advanced glycation end products in Alzheimer's disease
Xiao-Yan Xu et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2017)
Tau Proteins Cross the Blood-Brain Barrier
William A. Banks et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Stroke-induced blood-brain barrier breakdown along the vascular tree - No preferential affection of arteries in different animal models and in humans
Martin Krueger et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)
Age-associated physiological and pathological changes at the blood-brain barrier: A review
Franciska Erdo et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)
Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery
Simon G. Patching
MOLECULAR NEUROBIOLOGY (2017)
Barrier function in the peripheral and central nervous system-a review
A. K. Reinhold et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2017)
Blood-brain barrier-on-a-chip: Microphysiological systems that capture the complexity of the blood-central nervous system interface
Duc T. T. Phan et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2017)
Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease
Yu Yamazaki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
The vascular basement membrane in the healthy and pathological brain
Maj S. Thomsen et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)
Role of Vitamin D in Amyloid clearance via LRP-1 upregulation in Alzheimer's disease: A potential therapeutic target?
Parmi Patel et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2017)
Astrocytes contribute to Aβ-induced blood-brain barrier damage through activation of endothelial MMP9
Simona Federica Spampinato et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Soluble CD40 ligand contributes to blood-brain barrier breakdown and central nervous system inflammation in multiple sclerosis and neuromyelitis optica spectrum disorder
Hiroki Masuda et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
Astrocyte and Alzheimer's disease
Zhiyou Cai et al.
JOURNAL OF NEUROLOGY (2017)
Disruption of Bmal1 Impairs Blood-Brain Barrier Integrity via Pericyte Dysfunction
Ryota Nakazato et al.
JOURNAL OF NEUROSCIENCE (2017)
Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype
Shorena Janelidze et al.
NEUROBIOLOGY OF AGING (2017)
The blood-brain barrier in Alzheimer's disease
Elena Zenaro et al.
NEUROBIOLOGY OF DISEASE (2017)
CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice
Kailin Yin et al.
NEUROLOGICAL RESEARCH (2017)
ROLE OF THROMBIN-PAR1-PKCθ/δ AXIS IN BRAIN PERICYTES IN THROMBIN-INDUCED MMP-9 PRODUCTION AND BLOOD-BRAIN BARRIER DYSFUNCTION IN VITRO
Takashi Machida et al.
NEUROSCIENCE (2017)
The blood brain barrier in Alzheimer's disease
A. Chakraborty et al.
VASCULAR PHARMACOLOGY (2017)
Adiponectin controls the apoptosis and the expression of tight junction proteins in brain endothelial cells through AdipoR1 under beta amyloid toxicity
Juhyun Song et al.
CELL DEATH & DISEASE (2017)
Neurovascular Unit Dysfunction and Blood-Brain Barrier Hyperpermeability Contribute to Schizophrenia Neurobiology: A Theoretical integration of Clinical and experimental evidence
Souhel Najjar et al.
FRONTIERS IN PSYCHIATRY (2017)
The Role of Interleukin-18, Oxidative Stress and Metabolic Syndrome in Alzheimer's Disease
Johanna O. Ojala et al.
JOURNAL OF CLINICAL MEDICINE (2017)
Evolution of blood-brain-barrier permeability after acute ischemic stroke
Zamir Merali et al.
PLOS ONE (2017)
Regional early and progressive loss of brain pericytes but not vascular smooth muscle cells in adult mice with disrupted platelet-derived growth factor receptor-β signaling
Angellki Maria Nikolakopoulou et al.
PLOS ONE (2017)
Tauopathies - Focus on Changes at the Neurovascular Unit
Alena Michalicova et al.
CURRENT ALZHEIMER RESEARCH (2017)
LDL receptor blockade reduces mortality in a mouse model of ischaemic stroke without improving tissue-type plasminogen activator-induced brain haemorrhage: towards pre-clinical simulation of symptomatic ICH
Be'eri Niego et al.
FLUIDS AND BARRIERS OF THE CNS (2017)
Interactions of β-amyloid peptide with fibrinogen and coagulation factor XII may contribute to Alzheimer's disease
Hyung J. Ahn et al.
CURRENT OPINION IN HEMATOLOGY (2017)
Exacerbation of oxygen-glucose deprivation-induced blood-brain barrier disruption: potential pathogenic role of interleukin-9 in ischemic stroke
Sha Tan et al.
CLINICAL SCIENCE (2017)
Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease
Matthew R. Halliday et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)
Neuronal low-density lipoprotein receptor-related protein 1 (LRP1) enhances the anti-apoptotic effect of intravenous immunoglobulin (IVIg) in ischemic stroke
Ker Zhing Lok et al.
BRAIN RESEARCH (2016)
Blood-brain barrier and blood-cerebrospinal fluid barrier in normal and pathological conditions
Masaki Ueno et al.
BRAIN TUMOR PATHOLOGY (2016)
Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis
Sherman S. Leung et al.
CURRENT DIABETES REPORTS (2016)
Breakdown of the Cerebrovasculature and Blood-Brain Barrier: A Mechanistic Link Between Diabetes Mellitus and Alzheimer's Disease
Eric L. Goldwaser et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Intracerebral GM-CSF contributes to transendothelial monocyte migration in APP/PS1 Alzheimer's disease mice
De S. Shang et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)
Clearance systems in the brain-implications for Alzheimer diseaser (vol 11, pg 457, 2015)
Jenna M. Tarasoff-Conway et al.
NATURE REVIEWS NEUROLOGY (2016)
Chronic cerebral hypoperfusion-induced impairment of Aβ clearance requires HB-EGF-dependent sequential activation of HIF1α and MMP9
Anushruti Ashok et al.
NEUROBIOLOGY OF DISEASE (2016)
Imaging of Leukocyte Trafficking in Alzheimer's Disease
Enrica Pietronigro et al.
FRONTIERS IN IMMUNOLOGY (2016)
Statins Inhibit Fibrillary β-Amyloid Induced Inflammation in a Model of the Human Blood Brain Barrier
Jarred M. Griffin et al.
PLOS ONE (2016)
The β-amyloid peptide compromises Reelin signaling in Alzheimer's disease
Inmaculada Cuchillo-Ibanez et al.
SCIENTIFIC REPORTS (2016)
Matrix Metalloproteinase in Blood-Brain Barrier Breakdown in Dementia
Erica M. Weekman et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
The Designed Environment and How it Affects Brain Morphology and Mental Health
Jan A. Golembiewski
HERD-HEALTH ENVIRONMENTS RESEARCH & DESIGN JOURNAL (2016)
Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD)
Tuan Minh Do et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease
Yang Xiang et al.
ACTA NEUROPATHOLOGICA (2015)
In vitro discrimination of the role of LRP1 at the BBB cellular level: Focus on brain capillary endothelial cells and brain pericytes
Pietra Candela et al.
BRAIN RESEARCH (2015)
Establishment and Dysfunction of the Blood-Brain Barrier
Zhen Zhao et al.
CELL (2015)
The dynamic blood-brain barrier
James Keaney et al.
FEBS JOURNAL (2015)
Circulating soluble low-density lipoprotein receptor-related protein 1 (sLRP1) concentration is associated with hypercholesterolemia: A new potential biomarker for atherosclerosis
D. de Gonzalo-Calvo et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Amyloid β Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases
Marjana Brkic et al.
JOURNAL OF NEUROSCIENCE (2015)
Formation and maintenance of the BBB
Marie Blanchette et al.
MECHANISMS OF DEVELOPMENT (2015)
Blood-Brain Barrier Breakdown in the Aging Human Hippocampus
Axel Montagne et al.
NEURON (2015)
Low-Density Lipoprotein Receptor-Related Protein 6 (LRP6) Is a Novel Nutritional Therapeutic Target for Hyperlipidemia, Non-Alcoholic Fatty Liver Disease, and Atherosclerosis
Gwang-woong Go
NUTRIENTS (2015)
Blood-brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment
Mina Elahy et al.
IMMUNITY & AGEING (2015)
Iron transport across the blood-brain barrier: development, neurovascular regulation and cerebral amyloid angiopathy
Ryan C. McCarthy et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
The Impact of Docosahexaenoic Acid on Alzheimer's Disease: Is There a Role of the Blood-Brain Barrier?
Yijun Pan et al.
CURRENT CLINICAL PHARMACOLOGY (2015)
Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier
Melanie Kuntz et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
The Pericyte: A Forgotten Cell Type with Important Implications for Alzheimer's Disease?
Ethan A. Winkler et al.
BRAIN PATHOLOGY (2014)
Disruption of the blood-brain barrier in parkinson's disease: curse or route to a cure?
Heyne Lee et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2014)
The Role of Pericytes in Neurovascular Unit Remodeling in Brain Disorders
Ayman ElAli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
The potential mechanisms of Aβ-receptor for advanced glycation end-products interaction disrupting tight junctions of the blood-brain barrier in Alzheimer's disease
Wenbin Wan et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2014)
Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease
Zhiyou Cai et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2014)
The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer's disease
Takahisa Kanekiyo et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer's disease
Bo-Ryoung Choi et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2014)
The ?-Secretase Blocker DAPT Reduces the Permeability of the Blood-Brain Barrier by Decreasing the Ubiquitination and Degradation of Occludin During Permanent Brain Ischemia
Gen-Sheng Zhang et al.
CNS NEUROSCIENCE & THERAPEUTICS (2013)
Reduced Alzheimer's Disease Pathology by St. John's Wort Treatment is Independent of Hyperforin and Facilitated by ABCC1 and Microglia Activation in Mice
Jacqueline Hofrichter et al.
CURRENT ALZHEIMER RESEARCH (2013)
Influence of LRP-1 and Apolipoprotein E on Amyloid-beta Uptake and Toxicity to Cerebrovascular Smooth Muscle Cells
Wan Adriyani W. Ruzali et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
A Lipoprotein Receptor Cluster IV Mutant Preferentially Binds Amyloid-β and Regulates Its Clearance from the Mouse Brain
Abhay P. Sagare et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Decreased plasma levels of soluble low density lipoprotein receptor-related protein-1 (sLRP) and the soluble form of the receptor for advanced glycation end products (sRAGE) in the clinical diagnosis of Alzheimer's disease
Furu Liang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2013)
Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence
Souhel Najjar et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Changes in the blood-brain barrier status closely correlate with the rate of disease progression in patients with multiple system atrophy: A longitudinal study
Ji E. Lee et al.
PARKINSONISM & RELATED DISORDERS (2013)
Blood-brain barrier transport of amyloid beta peptides in efflux pump knock-out animals evaluated by in vivo optical imaging
Wandong Zhang et al.
FLUIDS AND BARRIERS OF THE CNS (2013)
ABCG2- and ABCG4-Mediated Efflux of Amyloid-β Peptide (1-40) at the Mouse Blood-Brain Barrier
Tuan Minh Do et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease
Rashid Deane et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Aβ1-42-RAGE Interaction Disrupts Tight Junctions of the Blood-Brain Barrier Via Ca2+-Calcineurin Signaling
Sun-Young Kook et al.
JOURNAL OF NEUROSCIENCE (2012)
Amyloid-β Contributes to Blood-Brain Barrier Leakage in Transgenic Human Amyloid Precursor Protein Mice and in Humans With Cerebral Amyloid Angiopathy
Anika M. S. Hartz et al.
STROKE (2012)
Low-Density Lipoprotein Receptor-Related Protein 1 Prevents Early Atherosclerosis by Limiting Lesional Apoptosis and Inflammatory Ly-6Chigh Monocytosis Evidence That the Effects Are Not Apolipoprotein E Dependent
Patricia G. Yancey et al.
CIRCULATION (2011)
Modelling the Neurovascular Unit and the Blood-Brain Barrier with the Unique Function of Pericytes
Elodie Vandenhaute et al.
CURRENT NEUROVASCULAR RESEARCH (2011)
Apolipoprotein E Regulates the Integrity of Tight Junctions in an Isoform-dependent Manner in an in Vitro Blood-Brain Barrier Model
Kazuchika Nishitsuji et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in mice
Markus Krohn et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Blood-brain barrier impairment is functionally correlated with clinical severity in patients of multiple system atrophy
Sook K. Song et al.
NEUROBIOLOGY OF AGING (2011)
Cerebral Amyloid Angiopathy, Blood-Brain Barrier Disruption and Amyloid Accumulation in SAMP8 Mice
Jaume del Valle et al.
NEURODEGENERATIVE DISEASES (2011)
Oxidative Stress and β-Amyloid Protein in Alzheimer's Disease
Zhiyou Cai et al.
NEUROMOLECULAR MEDICINE (2011)
ROLE OF Aβ-RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS INTERACTION IN OXIDATIVE STRESS AND CYTOSOLIC PHOSPHOLIPASE A2 ACTIVATION IN ASTROCYTES AND CEREBRAL ENDOTHELIAL CELLS
S. Askarova et al.
NEUROSCIENCE (2011)
A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid-β Production in Vivo
Jasvinder K. Atwal et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Is P-glycoprotein Involved in Amyloid-beta Elimination Across the Blood-Brain Barrier in Alzheimer's Disease?
S. Ohtsuki et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Transporters in the Brain Endothelial Barrier
M. Ueno et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Apical-to-Basolateral Transport of Amyloid-beta Peptides through Blood-Brain Barrier Cells is Mediated by the Receptor for Advanced Glycation End-Products and is Restricted by P-Glycoprotein
Pietra Candela et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
The Effects of a High-Energy Diet on Hippocampal Function and Blood-Brain Barrier Integrity in the Rat
Scott E. Kanoski et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Receptor for advanced glycation end products is upregulated in optic neuropathy of Alzheimer's disease
Michelle Y. Wang et al.
ACTA NEUROPATHOLOGICA (2009)
Lipopolysaccharide alters the blood-brain barrier transport of amyloid β protein: A mechanism for inflammation in the progression of Alzheimer's disease
Laura B. Jaeger et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Low-Density Lipoprotein Receptor-Related Protein 1 Promotes Cancer Cell Migration and Invasion by Inducing the Expression of Matrix Metalloproteinases 2 and 9
Heesang Song et al.
CANCER RESEARCH (2009)
Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer's disease
Ling Zhang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Receptor for advanced glycation end products: its role in Alzheimer's disease and other neurological diseases
Lih-Fen Lue et al.
FUTURE NEUROLOGY (2009)
Clearance of amyloid-β by circulating lipoprotein receptors
Abhay Sagare et al.
NATURE MEDICINE (2007)
Occludin is overexpressed in Alzheimer's disease and vascular dementia
Mihaela Oana Romanitan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2007)
Transport pathways for clearance of human Alzheimer's amyloid β-peptide and apolipoproteins E and J in the mouse central nervous system
Robert D. Bell et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Site-specific UBITh® amyloid-β vaccine for immunotherapy of Alzheimer's disease
Chang Yi Wang et al.
VACCINE (2007)
Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: Implications for drug therapy
Brinda S. Desai et al.
CELL TRANSPLANTATION (2007)
RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease
John E. Donahue et al.
ACTA NEUROPATHOLOGICA (2006)
Deficient cerebral clearance of vasculotropic mutant Dutch/Iowa double AB in human AβPP transgenic mice
Judianne Davis et al.
NEUROBIOLOGY OF AGING (2006)
Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia
E Emanuele et al.
ARCHIVES OF NEUROLOGY (2005)
The blood-brain barrier/neurovascular unit in health and disease
BT Hawkins et al.
PHARMACOLOGICAL REVIEWS (2005)
Cell biology of the neurovascular unit: Implications for drug delivery across the blood-brain barrier
JH McCarty
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2005)
Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease
ZH Wu et al.
NATURE MEDICINE (2005)
The blood-brain barrier: an overview - Structure, regulation, and clinical implications
P Ballabh et al.
NEUROBIOLOGY OF DISEASE (2004)
RAGE (Yin) versus LRP (Yang) balance regulates Alzheimer amyloid β-peptide clearance through transport across the blood-brain barrier
R Deane et al.
STROKE (2004)
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
R Deane et al.
NATURE MEDICINE (2003)
C766T low-density lipoprotein receptor-related protein 1 (LRP1) gene polymorphism and susceptibility to breast cancer
P Benes et al.
BREAST CANCER RESEARCH (2003)
Effect of endothelial cell polarity on β-amyloid-induced migration of monocytes across normal and AD endothelium
R Giri et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)
Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier
JD Huber et al.
TRENDS IN NEUROSCIENCES (2001)
β-Amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1
R Giri et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2000)
分享论文
